These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27059652)

  • 1. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry.
    Malkiel S; Jeganathan V; Wolfson S; Manjarrez Orduño N; Marasco E; Aranow C; Mackay M; Gregersen PK; Diamond B
    Arthritis Rheumatol; 2016 Sep; 68(9):2210-20. PubMed ID: 27059652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.
    Anolik JH; Barnard J; Cappione A; Pugh-Bernard AE; Felgar RE; Looney RJ; Sanz I
    Arthritis Rheum; 2004 Nov; 50(11):3580-90. PubMed ID: 15529346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of an IgG plasma cell checkpoint in patients with lupus.
    Suurmond J; Atisha-Fregoso Y; Marasco E; Barlev AN; Ahmed N; Calderon SA; Wong MY; Mackay MC; Aranow C; Diamond B
    J Allergy Clin Immunol; 2019 Apr; 143(4):1586-1597. PubMed ID: 30439406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosus.
    Jacobi AM; Zhang J; Mackay M; Aranow C; Diamond B
    PLoS One; 2009 Jun; 4(6):e5776. PubMed ID: 19488401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of self-reactive naïve and memory B cell reveals sequential defects in B cell tolerance checkpoints in Sjögren's syndrome.
    Corsiero E; Sutcliffe N; Pitzalis C; Bombardieri M
    PLoS One; 2014; 9(12):e114575. PubMed ID: 25535746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of memory B- and T-cell subsets in lupus nephritis patients.
    Kosalka J; Jakiela B; Musial J
    Folia Histochem Cytobiol; 2016; 54(1):32-41. PubMed ID: 27094637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
    Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
    Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
    Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
    Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95.
    Jacobi AM; Reiter K; Mackay M; Aranow C; Hiepe F; Radbruch A; Hansen A; Burmester GR; Diamond B; Lipsky PE; Dörner T
    Arthritis Rheum; 2008 Jun; 58(6):1762-73. PubMed ID: 18512812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
    Jacobi AM; Odendahl M; Reiter K; Bruns A; Burmester GR; Radbruch A; Valet G; Lipsky PE; Dörner T
    Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new CD21low B cell population in the peripheral blood of patients with SLE.
    Wehr C; Eibel H; Masilamani M; Illges H; Schlesier M; Peter HH; Warnatz K
    Clin Immunol; 2004 Nov; 113(2):161-71. PubMed ID: 15451473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro production of anti-nuclear antibodies by human peripheral blood mononuclear cells. Demonstration of T cell requirement and soluble inducing factor(s) for anti-nuclear antibodies triggering in patients with systemic lupus erythematosus.
    Mach PS; Kharouby M; Lutcher F; Olivier JL; Bazely N; Dougados M; Amor B
    Clin Exp Immunol; 1984 Sep; 57(3):535-40. PubMed ID: 6235994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of anti-interleukin-6 receptor blockade on circulating T and B cell subsets in patients with systemic lupus erythematosus.
    Shirota Y; Yarboro C; Fischer R; Pham TH; Lipsky P; Illei GG
    Ann Rheum Dis; 2013 Jan; 72(1):118-28. PubMed ID: 22858586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.